Thoughts on post-marketing evaluation of classical Chinese patent medicines based on clinical value.
10.19540/j.cnki.cjcmm.20210127.501
- Author:
Zhuo SONG
1
;
Zhi-Fei WANG
2
;
Yu WU
1
;
Yan-Ming XIE
2
;
Yu-Fei YANG
1
;
Yun XU
1
Author Information
1. Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences Beijing 100091, China.
2. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
Chinese patent medicine;
classical Chinese medicine;
clinical value;
post-marketing evaluation;
research characteristics
- MeSH:
China;
Drugs, Chinese Herbal;
Humans;
Marketing;
Medicine, Chinese Traditional;
Nonprescription Drugs
- From:
China Journal of Chinese Materia Medica
2021;46(8):1988-1993
- CountryChina
- Language:Chinese
-
Abstract:
Classical Chinese patent medicines(CPMs) are a kind of modern preparation developed from the experience of compatibility and application about ancient prescriptions. Its rich history of human use and reliable clinical efficacy imply the unique theoretical essence and precious value of traditional Chinese medicine(TCM). With the development of evidence-based medicine and the improvement of medical policy, it is particularly urgent to evaluate the clinical values of post-marketing classical CPMs. In this paper, some problems on the clinical value evaluation of CPMs would be described, and it is considered that the simplified evaluation procedures can lead to the lack of evidence for evaluating clinical value of CPMs, causing the difficulty in evaluating the quality of CPM, lack of R&D motivation of enterprises, low content of science and technology, and poor international development. Based on this background, it points out that the clinical value evaluation is the core of the post-marketing evaluation of the classical CPMs, and the eva-luation should be based on the direction of literature research and the latest practice. We should adhere to the research mode of combination disease with syndrome, and select the appropriate type of trials, with clinical efficacy, health economic benefits and safety eva-luation as the main content of the studies, in order to refine the indications and standardize the clinical positioning. Clinical value eva-luation is the basis and main content of post-marketing comprehensive researches on classic and famous CPMs to clarify their clinical value, obtain the conditions for continued marketingand standardize their clinical application, so as to optimize the evidence and quality service of classic and famous CPMs and inherit the core value concept of Chinese medicine.
